These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28220635)

  • 21. Forest loss shapes the landscape suitability of Kyasanur Forest disease in the biodiversity hotspots of the Western Ghats, India.
    Walsh MG; Mor SM; Maity H; Hossain S
    Int J Epidemiol; 2019 Dec; 48(6):1804-1814. PubMed ID: 31740967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monkey fever unbound.
    Stone R
    Science; 2014 Jul; 345(6193):130-1, 133. PubMed ID: 25013042
    [No Abstract]   [Full Text] [Related]  

  • 23. Kyasanur forest disease.
    Holbrook MR
    Antiviral Res; 2012 Dec; 96(3):353-62. PubMed ID: 23110991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of human infection with Kyasanur Forest Disease Virus.
    Devadiga S; Arunkumar G
    J Infect; 2022 Aug; 85(2):161-166. PubMed ID: 35609707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiences of Indian Council of Medical Research with tick-borne zoonotic infections: Kyasanur Forest disease & Crimean-Congo haemorrhagic fever in India with One Health focus.
    Mourya DT; Yadav PD; Patil DY; Sahay RR; Rahi M
    Indian J Med Res; 2021 Mar; 153(3):339-347. PubMed ID: 33906997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent ancestry of Kyasanur Forest disease virus.
    Mehla R; Kumar SR; Yadav P; Barde PV; Yergolkar PN; Erickson BR; Carroll SA; Mishra AC; Nichol ST; Mourya DT
    Emerg Infect Dis; 2009 Sep; 15(9):1431-7. PubMed ID: 19788811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occupational exposure of cashew nut workers to Kyasanur Forest disease in Goa, India.
    Patil DY; Yadav PD; Shete AM; Nuchina J; Meti R; Bhattad D; Someshwar S; Mourya DT
    Int J Infect Dis; 2017 Aug; 61():67-69. PubMed ID: 28627428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kyasanur forest disease: a state-of-the-art review.
    Gupta N; Wilson W; Neumayr A; Saravu K
    QJM; 2022 Jun; 115(6):351-358. PubMed ID: 33196834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular Immune Responses Against γ-Inactivated Antigen in the Recovered Cases of Kyasanur Forest Disease.
    Kaushal H; Kartaskar RS; Chiplunkar T; Yadav PD; Awate P; Potdar VA; Khalipe MM; Saraf C; Shete AM; Sahay RR; Das S; Chandrakant SA; Alagarasu K
    Viral Immunol; 2024 Mar; 37(2):101-106. PubMed ID: 38315741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kyasanur forest disease and climatic attributes in India.
    Singh P; Kumar P; Dhiman RC
    J Vector Borne Dis; 2022; 59(1):79-85. PubMed ID: 35708408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of host receptor interaction with envelop protein of Kyasanur forest disease virus and predicting suitable epitopes for vaccine candidate.
    Dey S; Pratibha M; Singh Dagur H; Rajakumara E
    J Biomol Struct Dyn; 2024 May; 42(8):4110-4120. PubMed ID: 37272880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New focus of Kyasanur Forest disease virus activity in a tribal area in Kerala, India, 2014.
    Tandale BV; Balakrishnan A; Yadav PD; Marja N; Mourya DT
    Infect Dis Poverty; 2015; 4():12. PubMed ID: 25750730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective Study of Kyasanur Forest Disease and Deaths among Nonhuman Primates, India, 1957-2020.
    Chakraborty S; Sander WE; Allan BF; Andrade FCD
    Emerg Infect Dis; 2021 Jul; 27(7):1969-1973. PubMed ID: 34152964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture.
    Cook BW; Ranadheera C; Nikiforuk AM; Cutts TA; Kobasa D; Court DA; Theriault SS
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004871. PubMed ID: 27479197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring potential inhibitors against Kyasanur forest disease by utilizing molecular dynamics simulations and ensemble docking.
    Kandagalla S; Novak J; Shekarappa SB; Grishina MA; Potemkin VA; Kumbar B
    J Biomol Struct Dyn; 2022; 40(24):13547-13563. PubMed ID: 34662258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of single step RT-PCR for detection of Kyasanur forest disease virus from clinical samples.
    Chaubal G; Sarkale P; Kore P; Yadav P
    Heliyon; 2018 Feb; 4(2):e00549. PubMed ID: 29560461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019.
    Munivenkatappa A; Yadav PD; Sahay RR; Sk K; Shete AM; Patil DY; Mohandas S; Jain R; Patil S; Sinha DP; Jayaswamy MM
    Infect Dis (Lond); 2024 Feb; 56(2):145-156. PubMed ID: 37966909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Early Passage Human Isolate of Kyasanur Forest Disease Virus Shows Acute Neuropathology in Experimentally Infected CD-1 Mice.
    Basu A; Yadav P; Prasad S; Badole S; Patil D; Kohlapure RM; Mourya DT
    Vector Borne Zoonotic Dis; 2016 Jul; 16(7):496-8. PubMed ID: 27171207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of human B and T cell adaptive immune responses to Kyasanur Forest disease virus infection.
    Devadiga S; McElroy AK; Prabhu SG; Arunkumar G
    Sci Rep; 2020 Sep; 10(1):15306. PubMed ID: 32943687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease.
    Majumdar T; Shete A; Yadav P; Patil S; Mali D; Waghmare A; Gawande P
    Int J Infect Dis; 2021 Jul; 108():226-230. PubMed ID: 34023493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.